Accent Microcell Ltd.

•

accentmicrocell.comBSE: -NSE: ACCENTMIC

Market Cap₹ 1,741 Cr.

Current Price

High / Low₹ 730 / 238

Stock P/E39.7

Book Value₹ 115

Price to Book3.09

Dividend Yield0.14 %

ROCE24.9 %

ROE18.7 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Dahej (SEZ Unit): 59.4% • Pirana: 40.2% • Unit III: 0.4%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 55.6% CAGR over last 5 years
Company is almost debt free
Company has a healthy return on capital (ROCE) of 26.2%
Company has a good return on equity (ROE) track record: 3 Years ROE 21.8%
Company has delivered good sales growth of 21.4% CAGR over last 5 years
Operating margins have improved to 16.2% from 10.9%

CONS

Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.51x)
Equity base is being diluted - shares outstanding up 85.3%
Valuation is stretched - P/E of 39.7 is well above its own 5-year median (16.2)
Though reporting repeated profits, the company pays out little dividend (5.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ACCENTMIC	725.75	39.70	1741.00	0.14	—	—	—	—	24.88	—

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

No standalone quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	133	166	197	245	265	349
	122	153	178	206	223	292
Operating Profit	11	13	19	39	42	57
OPM %	8.06%	7.83%	9.61%	16.08%	15.84%	16.24%
	2	2	2	3	6	7
Interest	3	3	3	1	0	1
Depreciation	4	4	4	4	4	5
Profit before Tax	6	8	15	37	44	58
Tax %	19.99%	22.35%	17.34%	17.41%	24.44%	24.72%
Net Profit	5	6	12	30	33	44
EPS	3.72	4.57	9.46	14.34	15.71	18.28
Dividend Payout %	8.96%	17.52%	8.46%	6.98%	6.36%	5.47%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 21%
3 Years:: 21%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 56%
3 Years:: 53%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 146%

RETURN ON EQUITY

10 Years:: —
5 Years:: 23%
3 Years:: 22%
Last Year:: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	13	13	21	21	24
	22	19	37	143	174	251
	31	24	23	11	1	0
Trade Payables	18	30	35	19	18	20
	5	8	5	19	36	39
Total Liabilities	81	95	113	213	250	334
	30	30	31	29	48	53
Capital Work in Progress	0	0	0	2	13	102
	32	40	42	33	34	32
	0	0	0	54	65	91
Cash & Bank	1	3	2	72	51	20
	17	22	38	23	40	36
Total Assets	81	95	113	213	250	334

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	6	17	10	12	25	19
Cash from Investing	-6	-4	-4	-82	-9	-49
Cash from Financing	-2	-10	-4	72	-14	36
	-3	1	-1	1	2	6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	55.09	55.09	55.09	55.09	55.44	55.44	55.47	53.02
	0.03	0.02	0.01	0.01	0.00	0.29	0.58	0.91
	1.62	1.66	2.19	2.88	3.29	3.57	3.59	3.54
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	43.26	43.23	42.70	42.01	41.27	40.70	40.36	42.53

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for ACCENTMIC

Loading news…

🤖

AI Stock Analyst

Accent Microcell Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

ACCENTMIC

725.75

39.70

1741.00

0.14

—

24.88

—

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

133

166

197

245

265

349

122

153

178

206

223

292

Operating Profit

OPM %

8.06%

7.83%

9.61%

16.08%

15.84%

16.24%

Interest

Depreciation

Profit before Tax

Tax %

19.99%

22.35%

17.34%

17.41%

24.44%

24.72%

Net Profit

EPS

3.72

4.57

9.46

14.34

15.71

18.28

Dividend Payout %

8.96%

17.52%

8.46%

6.98%

6.36%

5.47%

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

143

174

251

Trade Payables

Total Liabilities

113

213

250

334

Capital Work in Progress

102

Cash & Bank

Total Assets

113

213

250

334

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Cash from Investing

-6

-4

-82

-9

-49

Cash from Financing

-2

-10

-4

-14

-3

-1

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Mar 2024

Sep 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

55.09

55.44

55.47

53.02

0.03

0.02

0.01

0.00

0.29

0.58

0.91

1.62

1.66

2.19

2.88

3.29

3.57

3.59

3.54

Government

0.00

43.26

43.23

42.70

42.01

41.27

40.70

40.36

42.53

Accent Microcell Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Accent Microcell Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI